Glimisurf-Trio 1 Tablet SR
Marketer
Hypill Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glimisurf-Trio 1 Tablet SR
Tricor-Diabetics, a single-dose extended-release tablet, is classified as an antidiabetic medication. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Tricor-Diabetics should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on individual blood glucose response. Continued use is vital, even with seemingly controlled blood sugar, as abrupt cessation may lead to elevated glucose, risking complications such as nephropathy, retinopathy, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan encompassing a balanced diet, regular exercise, and weight management as recommended by your doctor. Lifestyle modifications significantly contribute to diabetes control. Hypoglycemia (low blood sugar) is a common adverse effect, characterized by sweating, dizziness, headache, and tremor. Learn to recognize and manage these symptoms; maintain regular mealtimes and carry a rapid-acting glucose source. Alcohol consumption elevates hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, cephalalgia, edema, visual disturbances, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes mellitus, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring, along with periodic blood cell and liver function tests, are essential.
Uses of Glimisurf-Trio 1 Tablet SR
Managing type 2 diabetes
Major Benefits of Glimisurf-Trio 1 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet without chewing, crushing, or breaking it. Administer Glimisurf-Trio 1 SR Tablet on an empty stomach.
Common Side effects of Glimisurf-Trio 1 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimisurf-Trio 1 Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimisurf-Trio 1 Tablet SR on an empty stomach.
How Glimisurf-Trio 1 Tablet SR works:
One extended-release Glimisurf-Trio tablet combines three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimisurf-Trio 1 Tablet SR with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimisurf-Trio 1 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimisurf-Trio tablet (1mg) is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Employing Glimisurf-Trio 1 Tablet SR is likely unsafe for individuals with kidney impairment and should be avoided. Medical advice is recommended. Furthermore, its use is discouraged in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Glimisurf-Trio 1 Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. A reduced initial dose is typically prescribed for individuals with mild to moderate liver disease; the medication is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Glimisurf-Trio 1 Tablet SR :
Should you forget to take your Glimisurf-Trio 1 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimisurf-Trio 1 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently